This new 269-page report from Venture Planning Group provides a comprehensive analysis in the Japanese endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH.
During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
Japanese Endocrine Function Testing Market 2014: Hospitals and Commercial Labs is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors.
Contains 269 pages and 15 tables
SIMILAR MARKET STUDIES
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Factor Assays testing specifically, will become more ...
January 2014 | $3500 | View Details >>
This strategic assessment of Takasago, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from VPGMarketResearch.com presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in ...
August 2015 | $0 | View Details >>
Complete report $9,800. DataPack (test volumes, sales forecasts, supplier shares) $6,400. “2014 Opportunities in the US Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current ...
September 2013 | $6400 | View Details >>
2016 Emerging US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices-Supplier Shares and Sales Forecasts for 10 Immunodiagnostic and NAT Procedures (DataPack)
This DataPack contains tables from VPGMarketResearch.com new report, 2016 Emerging US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts for 10 Immunodiagnostic and NAT Procedures. For pricing information on DataPack sections or individual tables, please contact Customer Service.
January 2016 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research